梅花生物2025年年度报告(英文版)

Meihua Holdings Group Co., Ltd.-Annual Report 20251 / 303Stock Code: 600873Stock Abbreviation: Meihua BioMeihua Holdings Group Co., Ltd.Annual Report 2025This is an English translation from the Annual Report 2025, in case ofany inconsistency, the Chinese Version shall prevail.Meihua Holdings Group Co., Ltd.-Annual Report 20252 / 303Important InformationI. The Company’s board of directors, directors, and officers guarantee that the contents of thisannual report are true, accurate, and complete without any false records, misleading statements,or material omissions and bear joint and several legal liability.II.All of the Company’s directors have attended the board meeting.III. RSM China CPA LLP (Special General Partnership) has issued an unqualified audit reportfor the Company.IV.Wang Aijun, the principal of the Company, Wang Lihong, the accounting principal, andWang Ailing, the principal of the accounting body (the accounting officer), hereby declare thatthey guarantee the truthfulness, accuracy, and completeness of the financial report in the annualreport.V.Profit distribution plan or capital reserve conversion plan for the Reporting Period asapproved by the BoardUpon deliberation and approval of the 2nd meeting of the 11th session of the board of directors, theprofit distribution plan (proposal) for 2025 is as follows: The Company plans to distribute cashdividends based on the total share capital registered on the equity distribution record date (afterdeducting shares in the share repurchase account). A cash dividend of 0.4279 yuan per share (inclusiveof tax) will be distributed to all shareholders. As of December 31, 2025, the Company had a total sharecapital of 2,804,241,650 shares, based on which the estimated total cash dividend distribution amountsto 1,199,935,002.04 yuan (inclusive of tax).The plan is yet to be submitted to the general meeting for deliberation. The amount that is actuallydistributed will be subject to the notification on equity distribution published by the Company. If there isany change in the Company’s total share capital before the registration date of equity distribution, thetotal amount to be distributed will remain unchanged, and the distribution proportion per share will beadjusted accordingly.The total cash dividends expected to be distributed by the Company for 2025, together with204,301,265.44 yuan used for share buyback and cancellation in 2025, represents approximately 42.80%of the net profit attributable to shareholders of the listed company for 2025.As of the end of the reporting period, the parent company's uncovered losses and their impact onmatters such as the company's dividend distribution.□Applicable √Not applicableVI. Risk Disclosure on Forward-Looking Statements√ Applicable Not applicableMeihua Holdings Group Co., Ltd.-Annual Report 20253 / 303This annual report involves forward-looking descriptions such as future plans, and such statementsdo not constitute material commitments for investors. Investor

立即下载
综合
2026-05-30
303页
2.37M
收藏
分享

梅花生物2025年年度报告(英文版),点击即可下载。报告格式为PDF,大小2.37M,页数303页,欢迎下载。

本报告共303页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共303页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关报告
热门报告
加入社群
回顶部
报告群
公众号
小程序
在线客服
收起